BR0116704A - Antìgenos de streptococcus pyogenes e fragmentos de dna correspondentes - Google Patents

Antìgenos de streptococcus pyogenes e fragmentos de dna correspondentes

Info

Publication number
BR0116704A
BR0116704A BR0116704-9A BR0116704A BR0116704A BR 0116704 A BR0116704 A BR 0116704A BR 0116704 A BR0116704 A BR 0116704A BR 0116704 A BR0116704 A BR 0116704A
Authority
BR
Brazil
Prior art keywords
streptococcus pyogenes
dna fragments
corresponding dna
antigens
pyogenes antigens
Prior art date
Application number
BR0116704-9A
Other languages
English (en)
Inventor
Denis Martin
Josee Hamel
Stephane Rioux
Patrick Rheault
Original Assignee
Shire Biochem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Biochem Inc filed Critical Shire Biochem Inc
Publication of BR0116704A publication Critical patent/BR0116704A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)

Abstract

"ANTìGENOS DE STREPTOCOCCUS PYOGENES E FRAGMENTOS DE DNA CORRESPONDENTES". A presente invenção refere-se a antígenos, mais particularmente antígenos de Streptococcus pyogenes (também chamado Streptococcus do grupo A (GAS) ) patógeno bacteriano que são úteis como componentes de vacina para terapia e/ou profilaxia.
BR0116704-9A 2000-12-21 2001-12-21 Antìgenos de streptococcus pyogenes e fragmentos de dna correspondentes BR0116704A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25694000P 2000-12-21 2000-12-21
PCT/CA2001/001853 WO2002050107A2 (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments

Publications (1)

Publication Number Publication Date
BR0116704A true BR0116704A (pt) 2003-12-23

Family

ID=22974225

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0116704-9A BR0116704A (pt) 2000-12-21 2001-12-21 Antìgenos de streptococcus pyogenes e fragmentos de dna correspondentes

Country Status (12)

Country Link
US (5) US7595057B2 (pt)
EP (1) EP1343895B1 (pt)
JP (1) JP4080876B2 (pt)
AT (1) ATE398677T1 (pt)
AU (2) AU2002216863B8 (pt)
BE (1) BE2021C506I2 (pt)
BR (1) BR0116704A (pt)
CA (2) CA2789252C (pt)
DE (1) DE60134494D1 (pt)
ES (1) ES2307564T3 (pt)
FR (1) FR21C1005I2 (pt)
WO (1) WO2002050107A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE398677T1 (de) * 2000-12-21 2008-07-15 Id Biomedical Corp Antigene aus streptococcus pyogenes und zugehörige dna-fragmente
GB0130228D0 (en) 2001-12-18 2002-02-06 Hansa Medica Ab Protein
US20070110763A1 (en) * 2003-08-15 2007-05-17 Stephane Rioux Polypeptides of streptococcus pyogenes
GB201502305D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502306D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854416A (en) * 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
US6287574B1 (en) 1995-03-17 2001-09-11 Biochem Pharma Inc. Proteinase K resistant surface protein of neisseria meningitidis
CA2321106C (en) * 1998-02-20 2013-07-23 Biochem Pharma Inc. Group b streptococcus antigens
GB9807890D0 (en) 1998-04-09 1998-06-10 Actinova Ltd Peptides
WO2000006736A2 (en) 1998-07-27 2000-02-10 Microbial Technics Limited Nucleic acids and proteins from group b streptococcus
EP2053126A1 (en) 1998-07-27 2009-04-29 Sanofi Pasteur Limited Streptococcus pneumoniae proteins and nucleic acid molecules
US7128918B1 (en) * 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
GB9828880D0 (en) 1998-12-31 1999-02-17 Actinova Ltd Protein
US7074415B2 (en) * 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
AU7227001A (en) * 2000-07-06 2002-01-21 Shire Biochem Inc Streptococcus pyogenes antigens
ATE547527T1 (de) * 2000-10-13 2012-03-15 Id Biomedical Corp Gruppe b streptococcus bvh-a2 und bvh-a3 antigene
EP2189473A3 (en) * 2000-10-27 2010-08-11 Novartis Vaccines and Diagnostics S.r.l. Nucleic and proteins from streptococcus groups A & B
ATE398677T1 (de) * 2000-12-21 2008-07-15 Id Biomedical Corp Antigene aus streptococcus pyogenes und zugehörige dna-fragmente
CA2438921C (en) * 2001-02-21 2012-04-10 Shire Biochem Inc. Streptococcus pyogenes polypeptides and corresponding dna fragments
EP1421098A4 (en) * 2001-04-13 2006-03-15 Wyeth Corp SURFACE PROTEINS OF STREPTOCOCCUS PYOGENES
CA2453062C (en) * 2001-07-06 2013-04-02 Shire Biochem Inc. Group b streptococcus bvh-a5 antigens and corresponding dna fragments
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
US7262024B2 (en) * 2001-12-20 2007-08-28 Id Biomedical Corporation Streptococcus antigens
WO2004007725A1 (en) * 2002-07-15 2004-01-22 Id Biomedical Corporation Polypeptide of streptococcus pyogenes
US20070110763A1 (en) * 2003-08-15 2007-05-17 Stephane Rioux Polypeptides of streptococcus pyogenes
JP2008544949A (ja) * 2004-10-08 2008-12-11 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 化膿性レンサ球菌のための免疫激性組成物および治療用組成物
US8133483B2 (en) * 2005-06-09 2012-03-13 Hansa Medical Ab Method of treating or preventing a disease or condition mediated by pathogenic IgG antibodies
US8309096B2 (en) * 2007-01-15 2012-11-13 Glaxosmithkline Biologicals S.A. Fusion protein
JP5722627B2 (ja) * 2007-09-14 2015-05-27 ジェノビス エービー ＦＣガンマ受容体−ＩｇＧ複合体の解離、ならびにＩｇＧの精製および検出のための方法およびキット
GB201003920D0 (en) * 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
GB201115841D0 (en) * 2011-09-13 2011-10-26 Genovis Ab Protein and method
GB201316744D0 (en) * 2013-09-20 2013-11-06 Genovis Ab Method
GB201416849D0 (en) * 2014-09-24 2014-11-05 Genovis Ab Method

Also Published As

Publication number Publication date
ES2307564T9 (es) 2021-04-26
FR21C1005I2 (fr) 2022-01-14
AU1686302A (en) 2002-07-01
EP1343895B1 (en) 2008-06-18
US20150017684A1 (en) 2015-01-15
DE60134494D1 (de) 2008-07-31
CA2432525A1 (en) 2002-06-27
US20130136760A1 (en) 2013-05-30
EP1343895A2 (en) 2003-09-17
ES2307564T3 (es) 2008-12-01
US20040097706A1 (en) 2004-05-20
CA2789252C (en) 2016-11-15
US7595057B2 (en) 2009-09-29
AU2002216863B8 (en) 2008-03-20
US20100119507A1 (en) 2010-05-13
WO2002050107A3 (en) 2003-04-10
CA2432525C (en) 2012-11-27
US20160326221A1 (en) 2016-11-10
CA2789252A1 (en) 2002-06-27
US8298551B2 (en) 2012-10-30
US8821895B2 (en) 2014-09-02
FR21C1005I1 (pt) 2021-03-26
WO2002050107A2 (en) 2002-06-27
JP2004524014A (ja) 2004-08-12
ATE398677T1 (de) 2008-07-15
BE2021C506I2 (pt) 2021-05-31
AU2002216863B2 (en) 2008-02-28
JP4080876B2 (ja) 2008-04-23
US9340586B2 (en) 2016-05-17

Similar Documents

Publication Publication Date Title
BR0213207A (pt) remodelagem e glicoconjugação de peptìdeos
FR21C1005I2 (fr) Antigenes de streptococcus pyogenes et fragments d'adn correspondants
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
NZ524888A (en) Nucleic acids and proteins from streptococcus groups A & B
ECSP055584A (es) Proceso para la preparación de fibrinógeno
ATE360706T1 (de) Peptidakzeptor ligationsverfahren
BR9910089A (pt) Composições e antìgenos de neisseria meningitidis
CY1109683T1 (el) Αντιγονα του streptococcus pyogenes
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
BR0113286A (pt) Pirazóis substituìdos
BR0112497A (pt) Antìgenos de streptococcus pyogenes
WO2008108830A8 (en) Immunogenic and therapeutic compositions for streptococcus pyogenes
BR0309570A (pt) Fatores camp quiméricos para vacinação contra infecção por streptococcus
BR0209128A (pt) Compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
GB0216002D0 (en) Process and composition
BR0315178A (pt) Eritropoietina: remodelagem e glicoconjugação de eritropoietina
BR0207447A (pt) Polipeptìdeos e fragmentos de dna correspondentes de streptococcus pyogenes úteis como componentes de vacina
BR0215588A (pt) Compostos imunoefetores
BR0109164A (pt) Anticorpos monoclonais para o receptor humano para ldl, produção e uso dos mesmos
BR0105071A (pt) Processo para produção de óxido linaloólico ou de misturas que contêm óxido linaloólico
DE60234772D1 (de) Gruppe-b streptococcus antigene und entsprechende dna-fragmente
BR0113170A (pt) Processo para a preparação de dinapsolina
BR9805135A (pt) ilato sintase de neospora.
WO2002088178A8 (en) Antigens of group b streptococcus and corresponding dna fragments
BR0209758A (pt) Hepta-, octa- e nonapeptìdeos possuindo atividade anti-angiogênica

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: SHIRE BIOCHEM INC. (CA)

Free format text: ALTERADA A SEDE DO TITULAR CONFORME REQUERIDA ATRAVES DA PETICAO NO 020050112580/RJ DE 11/10/2005.

B25A Requested transfer of rights approved

Owner name: ID BIOMEDICAL CORPORATION (CA)

Free format text: TRANSFERIDO DE: SHIRE BIOCHEM INC.

B25G Requested change of headquarter approved

Owner name: ID BIOMEDICAL CORPORATION (CA)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 018070079810/SP DE 04/12/2007.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]